Both in Biotechnology
Agenus vs Kyverna Therapeutics
Over the past year AGEN returned +68.0% and KYTX returned −25.0%; their daily moves had a correlation of 0.16.
AGEN +68.0% KYTX −25.0%Growth of $1, one year, split-adjusted
| Metric | AGEN | KYTX |
|---|---|---|
| Price | $6.67 | $5.16 |
| Market cap | $301.2M | $319.1M |
| Today | +2.14% | −1.15% |
| 1 month | −23.6% | −18.4% |
| 6 months | +60.0% | −44.0% |
| Year to date | +112.4% | −45.1% |
| 1 year | +68.0% | −26.0% |
| Revenue growth (YoY) | +34.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1.7% | — |
| P/E (TTM) | 3.3× | — |
| Price / sales | 2.3× | — |
| Net cash | -$11.3M | $174.4M |
| Dividend yield | — | — |
| Volatility (60d) | 88.6% | 59.9% |
| Short % of float | 16.6% | 26.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).